Bicyclol

双环醇

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBicyclol
Drug Alias Name百赛诺SY-801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsHepatitis, ChronicChemical and Drug Induced Liver InjuryHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Union Pharmaceutical Factory
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Union Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsChemical and Drug Induced Liver InjuryHepatitis B
Inactive IndicationsHepatitis, Chronic

Other Information

ATC CodeJ05AX
Related LinksN/A